Home / Healthcare

Healthcare

FDA Greenlights Madrigal Pharmaceuticals’ Drug as First-Ever Treatment for Widespread NASH Liver Disease

FDA Greenlights Madrigal Pharmaceuticals' Drug as First-Ever Treatment for Widespread NASH Liver Disease

On Thursday, the Food and Drug Administration granted approval for the inaugural treatment targeting a prevalent and potentially fatal liver condition impacting millions globally. This landmark decision signifies a significant breakthrough for Madrigal Pharmaceuticals, distinguishing it from numerous larger competitors who have struggled or are still striving to penetrate this ...

Read More »

Pfizer Ceases Production of Dual-Dose Weight Loss Medication Following Elevated Incidence of Adverse Effects

Pfizer Ceases Production of Dual-Dose Weight Loss Medication Following Elevated Incidence of Adverse Effects

On Friday, Pfizer announced the discontinuation of the development of the twice-daily variant of its experimental weight loss pill. This decision follows a mid-stage clinical study where obese patients experienced substantial weight loss while facing challenges in tolerating the drug. The pharmaceutical company noted elevated rates of adverse side effects, ...

Read More »

Researchers Identify ‘Microplastics’ in Human Heart for the First Time

Researchers Identify 'Microplastics' in Human Heart for the First Time

In a significant breakthrough, Chinese scientists from Beijing Anzhen Hospital uncovered a groundbreaking revelation during their examination of heart tissue from 15 patients who had undergone cardiovascular surgery. The proliferation of plastics has unleashed serious repercussions on our planet, giving rise to a multitude of environmental challenges. The insidious spread ...

Read More »

FDA Approves Jardiance and Synjardy for Enhancing Blood Sugar Control in Pediatric Type 2 Diabetes Patients

FDA Approves Jardiance and Synjardy for Enhancing Blood Sugar Control in Pediatric Type 2 Diabetes Patients

The U.S. Food and Drug Administration granted approval to Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as supplementary treatments to diet and exercise. These medications aim to enhance blood sugar control in children aged 10 years and above who are diagnosed with type 2 diabetes. This recent approval signifies ...

Read More »